MASTOPATHY: A NEW PERSPECTIVE ON AN OLD PROBLEM FROM A GYNECOLOGIST’S POINT OF VIEW

Abstract

Abstract: Mastopathy is one of the most common benign breast disorders, affecting 30–70% of women, with higher prevalence in those with gynecological conditions. This study evaluates the clinical efficacy and safety of prolonged-use monophasic microdose gestodene-containing combined oral contraceptive (COC) in women with diffuse fibrocystic mastopathy. A total of 60 women aged 18–45 were observed; 30 received the COC in a 63/7 prolonged regimen, while 30 were treated without hormonal therapy. Assessment included ultrasound, mammography, clinical examination, and patient-reported symptoms.